PREDICTION OF MYELOTOXICITY BASED ON BONE MARROW RADIATION-ABSORBED DOSE: RADIOIMMUNOTHERAPY STUDIES USING 90Y-AND 177LU-LABELED J591 ANTIBODIES SPECIFIC FOR PROSTATE-SPECIFIC MEMBRANE ANTIGEN

VALLABHAJOSULA, S., GOLDSMITH, S.J., & HAMACHER, K.A.. (2005). PREDICTION OF MYELOTOXICITY BASED ON BONE MARROW RADIATION-ABSORBED DOSE: RADIOIMMUNOTHERAPY STUDIES USING 90Y-AND 177LU-LABELED J591 ANTIBODIES SPECIFIC FOR PROSTATE-SPECIFIC MEMBRANE ANTIGEN. JOURNAL OF NUCLEAR MEDICINE, 46(5), 850-858. SID. https://sid.ir/paper/643099/en

VALLABHAJOSULA S., GOLDSMITH S.J., HAMACHER K.A.. PREDICTION OF MYELOTOXICITY BASED ON BONE MARROW RADIATION-ABSORBED DOSE: RADIOIMMUNOTHERAPY STUDIES USING 90Y-AND 177LU-LABELED J591 ANTIBODIES SPECIFIC FOR PROSTATE-SPECIFIC MEMBRANE ANTIGEN. JOURNAL OF NUCLEAR MEDICINE[Internet]. 2005;46(5):850-858. Available from: https://sid.ir/paper/643099/en

S. VALLABHAJOSULA, S.J. GOLDSMITH, and K.A. HAMACHER, “PREDICTION OF MYELOTOXICITY BASED ON BONE MARROW RADIATION-ABSORBED DOSE: RADIOIMMUNOTHERAPY STUDIES USING 90Y-AND 177LU-LABELED J591 ANTIBODIES SPECIFIC FOR PROSTATE-SPECIFIC MEMBRANE ANTIGEN,” JOURNAL OF NUCLEAR MEDICINE, vol. 46, no. 5, pp. 850–858, 2005, [Online]. Available: https://sid.ir/paper/643099/en